NOMAD POWER SOLUTIONS, INC. Grants Receivable, Current
NOMAD POWER SOLUTIONS, INC. (NMAD) had Grants Receivable, Current of $0 as of 2011-12-31, per its 10-K filed 2012-03-29.
Discontinued › Notes › Nontrade Receivables › Nontrade Receivables, Current
us-gaap:GrantsReceivableCurrent · last filed 2012-03-29
- 2011-12-31: Grants Receivable, Current $0.00.
- 2011-09-30: Grants Receivable, Current $0.00.
- 2011-06-30: Grants Receivable, Current $0.00.
- 2010-12-31: Grants Receivable, Current $116.48K.
| Period end | Grants Receivable, Current |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-03-29 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-10 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-12 |
| 2010-12-31 | $116.48K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |